Enhancing Anticoagulation Monitoring and Therapy in Patients Undergoing Microvascular Reconstruction in Maxillofacial Surgery: A Prospective Observational Trial.
coagulation monitoring
free flap thrombosis
maxillofacial surgery
point-of-care coagulation
viscoelastic testing
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
27 Jul 2022
27 Jul 2022
Historique:
received:
13
06
2022
revised:
22
07
2022
accepted:
25
07
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
In reconstructive surgery, loss of a microvascular free flap due to perfusion disorders, especially thrombosis, is a serious complication. In recent years, viscoelastic testing (VET) has become increasingly important in point-of-care (POC) anticoagulation monitoring. This paper describes a protocol for enhanced anticoagulation monitoring during maxillofacial flap surgery. The aim of the study will be to evaluate, in a controlled setting, the predictive value of POC devices for the type of flap perfusion disorders due to thrombosis or bleeding. VET, Platelet monitoring (PM) and standard laboratory tests (SLT) are comparatively examined. This study is an investigator-initiated prospective trial in 100 patients undergoing maxillofacial surgery. Patients who undergo reconstructive surgery using microvascular-free flaps will be consecutively enrolled in the study. All patients provide blood samples for VET, PM and SLT at defined time points. The primary outcome is defined as free flap loss during the hospital stay. Statistical analyses will be performed using t-tests, including the Bonferroni adjustment for multiple comparisons. This study will help clarify whether VET can improve individualized patient care in reconstruction surgery. A better understanding of coagulation in relation to flap perfusion disorders may allow real-time adaption of antithrombotic strategies and potentially prevent flap complications.
Sections du résumé
BACKGROUND
BACKGROUND
In reconstructive surgery, loss of a microvascular free flap due to perfusion disorders, especially thrombosis, is a serious complication. In recent years, viscoelastic testing (VET) has become increasingly important in point-of-care (POC) anticoagulation monitoring. This paper describes a protocol for enhanced anticoagulation monitoring during maxillofacial flap surgery.
OBJECTIVE
OBJECTIVE
The aim of the study will be to evaluate, in a controlled setting, the predictive value of POC devices for the type of flap perfusion disorders due to thrombosis or bleeding. VET, Platelet monitoring (PM) and standard laboratory tests (SLT) are comparatively examined.
METHODS/DESIGN
METHODS
This study is an investigator-initiated prospective trial in 100 patients undergoing maxillofacial surgery. Patients who undergo reconstructive surgery using microvascular-free flaps will be consecutively enrolled in the study. All patients provide blood samples for VET, PM and SLT at defined time points. The primary outcome is defined as free flap loss during the hospital stay. Statistical analyses will be performed using t-tests, including the Bonferroni adjustment for multiple comparisons.
DISCUSSION
CONCLUSIONS
This study will help clarify whether VET can improve individualized patient care in reconstruction surgery. A better understanding of coagulation in relation to flap perfusion disorders may allow real-time adaption of antithrombotic strategies and potentially prevent flap complications.
Identifiants
pubmed: 36013177
pii: jpm12081229
doi: 10.3390/jpm12081229
pmc: PMC9410460
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Auris Nasus Larynx. 2010 Apr;37(2):212-6
pubmed: 19700250
Plast Reconstr Surg Glob Open. 2021 Aug 12;9(8):e3769
pubmed: 34408964
Int J Oral Maxillofac Surg. 2017 Aug;46(8):941-945
pubmed: 28416356
Plast Reconstr Surg. 2012 Jul;130(1):105-113
pubmed: 22418714
Br J Anaesth. 2021 Mar;126(3):590-598
pubmed: 33422287
Minerva Anestesiol. 2022 Jul-Aug;88(7-8):615-628
pubmed: 35416466
Plast Reconstr Surg. 1998 Sep;102(3):722-32; discussion 733-4
pubmed: 9727437
Thromb Haemost. 2022 Jun 07;:
pubmed: 35672013
Am J Cardiol. 2006 Nov 20;98(10A):4N-10N
pubmed: 17097417
Ann Plast Surg. 2013 Jul;71(1):68-71
pubmed: 23123611
J Am Coll Surg. 2016 Apr;222(4):347-55
pubmed: 26920989
J Craniomaxillofac Surg. 2014 Dec;42(8):1610-3
pubmed: 24954764
Hamostaseologie. 2009 Aug;29(3):279-84
pubmed: 19644601
Anesthesiology. 2021 Mar 1;134(3):366-369
pubmed: 33417671
J Am Coll Cardiol. 2009 Mar 10;53(10):849-56
pubmed: 19264241
Int J Oral Maxillofac Surg. 2012 Jun;41(6):739-43
pubmed: 22424757
Diagnostics (Basel). 2020 Feb 21;10(2):
pubmed: 32098161
Microsurgery. 2014 Jul;34(5):339-44
pubmed: 24318866
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Korean J Anesthesiol. 2021 Apr;74(2):91-102
pubmed: 33440114
Thromb Res. 2019 Nov;183:146-152
pubmed: 31678709
Thromb J. 2021 Mar 16;19(1):18
pubmed: 33726769
Z Gesamte Exp Med. 1951;117(2):189-203
pubmed: 14836887
Head Neck. 2009 Oct;31(10):1289-96
pubmed: 19373778
Ann Plast Surg. 2018 Feb;80(2S Suppl 1):S15-S20
pubmed: 29369911
Int J Oral Maxillofac Surg. 2014 Sep;43(9):1059-63
pubmed: 25022830
Platelets. 2007 May;18(3):199-206
pubmed: 17497431
Ann Plast Surg. 2015 May;74(5):621-32
pubmed: 23038130
ANZ J Surg. 2020 Apr;90(4):413-414
pubmed: 31535453
J Trauma Acute Care Surg. 2014 Dec;77(6):811-7; discussion 817
pubmed: 25051384
Ann R Coll Surg Engl. 2012 Jan;94(1):43-51
pubmed: 22524928
Arch Plast Surg. 2019 Nov;46(6):572-579
pubmed: 31775211
Oral Oncol. 2022 Jan;124:105515
pubmed: 34481704